The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Statement re Covid-19 and Update

1 May 2020 07:00

RNS Number : 5754L
Quadrise Fuels International PLC
01 May 2020
 

1 May 2020

 

 

Quadrise Fuels International plc

("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")

 

Further Statement re Covid-19

 

Update on Business Development Activities and Funding Position

 

Following the adoption of proactive measures taken in early March 2020 to protect the Group's employees and business, QFI has continued to make progress in its business development and research activities.

 

When the Company announced its interim results on 30 March 2020, it was confirmed that initiatives to reduce costs had enabled the Company to extend its period of operation on current funds to 31 March 2021. The Company is now pleased to announce that a total of over £0.5m in cost savings and reduced financial commitments have been achieved, which will enable the Company to continue to operate through to mid Q2 2021, based on existing funds. This provides the Company with a significant cash runway before new funding is required.

 

Savings have been made through a variety of actions; reducing the overall costs of the board, consultant cost reductions, revisions to the office lease, and furloughing of certain members of staff. We are also seeking to access to other UK Government support schemes where this is appropriate.

 

Our equipment and MSAR® fuel for the first phase pilot plant trial in Morocco are now on site and the joint project team remains in regular contact to progress the second phase activities for the trials on the client's larger commercial units. When we can gain safe access to the site, we will be able to commence the pilot trial and further progress the FEED study. The expected successful outcome of the pilot trial, and submission of the FEED study, will release payment for phase 2 in advance of the commercial trial agreements.

 

We have received extensive information from the client in South America and the techno-economic studies are being finalised, prior to being shared with Freepoint Commodities and the client.

 

In the marine sector, discussions with the two scrubber-equipped major shipping companies are continuing, alongside our continued investigations into the physical bunker supply business with stakeholders.

 

In the Kingdom of Saudi Arabia, we are continuing to follow-up via Al Khafrah following the recent meeting in Riyadh at the Head Office of the power company. The next stage is a meeting with the management team from the western province where the trial would be held. Whilst our preference for this key meeting would be face to face, we are reviewing other alternatives with Al Khafrah to maintain momentum during Ramadan.

 

We remain in regular contact with our other clients and relevant agents, but at this stage there is nothing material to report on those activities beyond that disclosed in the interim results.

 

Quadrise's London office has been closed since mid-March, with all staff working efficiently from home. Using collaborative working systems adopted and used regularly since 2019. this transition has worked very smoothly for both internal meetings and meetings with clients and other stakeholders. Our research and operational support facility in Essex, ("QRF"), continues to operate as staff live locally, commute by car or foot, and can socially distance safely whilst working there. Emulsion production and testing at QRF continues to support business development, patent applications and general MSAR® research development and innovation initiatives.

 

Mike Kirk, Chairman of QFI, said:

 

"We are pleased that we have been able to deliver a material extension to our cash runway, which will now take us to mid Q2 2021. This provides us the opportunity to progress our business development opportunities in earnest for over one-year - an increase of around 5 months to that forecasted at the beginning of 2020.

 

Despite the current restrictions, we are continuing our activities to very good effect; with material progress in the second phase of work in Morocco; the techno-economic studies with the client in South America and discussions on multiple opportunities in the marine sector.

 

Although the oil market is significantly disrupted at this time, we do not believe our clients are basing their medium to long-term plans on the current pricing environment and so we remain confident of the opportunities to progress our projects to commercialisation, which will underpin any future funding needed in the period up to mid Q2 2021."

 

For additional information, please contact:

 

Quadrise Fuels International Plc +44 (0)20 7031 7321

Mike Kirk, Chairman

Jason Miles, Chief Executive Officer

 

Nominated Adviser

Cenkos Securities plc +44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

 

Joint Brokers 

Peel Hunt LLP +44 (0)20 7418 8900

Richard Crichton

David McKeown

 

Joint Brokers

Shore Capital Stockbrokers Limited +44 (0)20 7408 4090

Toby Gibbs

Fiona Conroy

 

Public & Investor Relations

FTI Consulting +44 (0)20 3727 1000

Ben Brewerton

Ntobeko Chidavaenzi

 

 

The information communicated within this announcement was deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 prior to the release of this announcement. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDIMMPTMTMJBLM
Date   Source Headline
13th Mar 20237:00 amRNSProposed Change of Name
6th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20237:00 amRNSWärtsilä Testing Update
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSMorocco Project Update
1st Feb 20237:00 amRNSBlock Admission Cancellation and Interim Review
31st Jan 20237:00 amRNSAppointment of New Auditor
30th Jan 20237:00 amRNSRe-Issue of Historical Share Options
16th Jan 20237:00 amRNSBusiness Update
29th Nov 20222:23 pmEQSQuadrise Fuels International (QFI): Key role in transitioning to net-zero
25th Nov 20222:16 pmRNSResult of AGM
25th Nov 20227:00 amRNSAGM Statement
23rd Nov 20227:00 amRNSPublication of Sustainability Report
15th Nov 20227:00 amRNSExtension of Exclusive Agreement with Nouryon
28th Oct 20224:48 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20227:00 amRNSFinal Results and Notice of AGM
21st Sep 20227:00 amRNSJoint Development Agreement with Vertoro
14th Sep 20227:00 amRNSNotice of Results and Investor Presentation
4th Aug 20227:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 202210:52 amRNSDirector/PDMR Dealing
1st Aug 20229:30 amRNSBlock Admission Interim Review
27th Jul 20227:00 amRNSFramework Agreement with MSC Shipmanagement
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
15th Jul 20225:40 pmRNSHolding(s) in Company
16th Jun 20227:00 amRNSIssue of Warrants
13th Jun 20227:30 amRNSMaterial Transfer & Cooperation Agreement
13th Jun 20227:00 amRNSAddendum to Representation Agreement
9th May 20227:00 amRNSOperational Update
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20228:28 amRNSCommercial Development Agreement with Valkor
28th Mar 20227:00 amRNSInterim Results
1st Feb 20223:00 pmRNSBlock Admission Interim Review
1st Feb 20228:44 amRNSReplacement:Appointment of Non-Executive Chairman
1st Feb 20227:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20227:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 202211:57 amRNSHolding(s) in Company
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAppointment of Chief Operating Officer
29th Dec 20214:42 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
15th Dec 20215:05 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.